Title,Author(s),id,Journal,BBCite,Cited (articles),Cited (cases),Accessed,Topics
The Paradox of Legal Equivalents and Scientific Equivalence: Reconciling Patent Law's Doctrine of Equivalents with the FDA's Bioequivalence Requirement [article],"Freilich, Janet (Cited 36 times)",9843,"SMU Law Review, Vol. 66, Issue 1 (Winter 2013), pp. 59-110",66 S.M.U. L. Rev. 59 (2013),13,na,19,na
Patent Infringement in the Context of Follow-on Biologics [article],"Freilich, Janet (Cited 36 times)",9843,"Stanford Technology Law Review, Vol. 16, Issue 1 (Fall 2012), pp. 9-50",16 Stan. Tech. L. Rev. 9 (2012-2013),11,na,20,na
The Uniformed Topograhy of Patent Scope [article],"Freilich, Janet (Cited 36 times)",9843,"Stanford Technology Law Review, Vol. 19, Issue 1 (Fall 2015), pp. 150-195",19 Stan. Tech. L. Rev. 150 (2015-2016),11,na,6,na
Towards Patent Standardization [article],"Freilich, Janet (Cited 36 times); Kesan, Jay P. (Cited 1130 times)",9843,"Harvard Journal of Law & Technology (Harvard JOLT), Vol. 30, Special Symposium (2017), pp. 233-256",30 Harv. J. L. & Tech. 233 (2016-2017),1,na,17,na
Patent Infringement in the Context of Follow-on Biologics,"Freilich, Janet (Cited 36 times)",9843,na,"Freilich, Janet (Cited 36 times)",na,na,na,na
Patent Clutter [article],"Freilich, Janet (Cited 36 times)",9843,"Iowa Law Review, Vol. 103, Issue 3 (March 2018), pp. 925-984",103 Iowa L. Rev. 925 (2017-2018),na,na,57,na
